先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02096 先声药业

交易中 04-02 14:28:37

13.490

-0.030

-0.22%

最高13.730	最低13.030	成交量780.40万
今开13.530	昨收13.520	日振幅5.18%
总市值350.20亿	流通市值350.20亿	总股本25.96亿
成交额1.04亿	换手率0.30%	流通股本25.96亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02096","market":"HK","secType":"STK","nameCN":"先声药业","latestPrice":13.49,"timestamp":1775111227256,"preClose":13.52,"halted":0,"volume":7804000,"delay":0,"changeRate":-0.0022189349112425563,"floatShares":2596000000,"shares":2596000000,"eps":0.6140818821611626,"marketStatus":"交易中","change":-0.03,"latestTime":"04-02 14:28:37","open":13.53,"high":13.73,"low":13.03,"amount":104080507,"amplitude":0.051775,"askPrice":13.49,"askSize":24000,"bidPrice":13.48,"bidSize":18000,"shortable":3,"etf":0,"ttmEps":0.6140818821611626,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1775117400000},"marketStatusCode":2,"adr":0,"listingDate":1603728000000,"exchange":"SEHK","adjPreClose":13.52,"dividendRate":0.015114,"openAndCloseTimeList":[[1775093400000,1775102400000],[1775106000000,1775116800000]],"volumeRatio":1.256042,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02096","defaultTab":"news","newsList":[{"id":"2623390139","title":"交银国际：升先声药业(02096)目标价至17.7港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2623390139","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623390139?lang=zh_cn&edition=full","pubTime":"2026-03-30 16:34","pubTimestamp":1774859659,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，将先声药业目标价上调至17.7港元，维持“买入”评级及行业重点推荐。公司2025年收入和经调整净利润分别同比增长16.5%和27.1%，分别达77.3亿和12.8亿元人民币，剔除授权许可收入后的产品收入增速为9.5%。管理层预计，2026年将有IL-4R和流感药两款新品获批上市、叠加与BI的合作4,200万欧元首付款确认收入，驱动收入和经调整净利润达到100亿和16亿元人民币左右，对应约30%的增速。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1421716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623678703","title":"部分创新药概念股逆市上扬 荣昌生物(09995)涨4.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623678703","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623678703?lang=zh_cn&edition=full","pubTime":"2026-03-30 10:23","pubTimestamp":1774837415,"startTime":"0","endTime":"0","summary":"金吾财讯 | 部分创新药概念股逆市上扬，荣昌生物 涨4.99%，康方生物涨4.75%，诺诚健华涨3.66%，先声药业涨2.73%，远大医药涨2.65%，和黄医药涨1.37%。据人民日报从国家药监局获悉，今年截至目前，我国创新药对外授权交易总额超过600亿美元，接近2025年全年的一半。今年截至3月27日，我国共批准上市10款创新药，其中8款是中国原创新药。2025年，我国批准创新药76个，创历史新高；创新药对外授权交易总金额突破1300亿美元，同样创历史新高。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MmQ2MzI0NzdkYTM0MjU4ODU0NDE5OWM2MjQ0NmE1ZTExMDg1Mjk2Mjc3MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977637","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926","09995","BK1574","LU1064131003.USD","LU2476274308.USD","BK0239","LU0348784397.USD","LU0417516571.SGD","LU0561508036.HKD","LU0417516902.SGD","BK1191","BK1587","LU2488822045.USD","06978","09969","LU0417516738.SGD","688331","LU0634319403.HKD","02096","LU2476274720.SGD","BK1588","BK1583","LU2148510915.USD","LU0348735423.USD","LU1720050803.USD","00013","LU1961090484.USD","LU0348825331.USD","LU0540923850.HKD","IE00B543WZ88.USD","LU0348783233.USD","BK1161","LU1794554557.SGD","LU1064130708.USD","LU2328871848.SGD","IE00BPRC5H50.USD","LU2778985437.USD","LU0348766576.USD","LU0348827113.USD","IE00B5MMRT66.SGD","00512","LU1969619763.USD","159992","LU0348767384.USD","LU2399975544.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622257448","title":"恒瑞老将正式执掌先声药业 昔日内幕交易引合规评估","url":"https://stock-news.laohu8.com/highlight/detail?id=2622257448","media":"经济参考网","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622257448?lang=zh_cn&edition=full","pubTime":"2026-03-27 19:42","pubTimestamp":1774611748,"startTime":"0","endTime":"0","summary":"从2025年12月首次以总裁身份出现在江苏省肿瘤医院与先声药业（02096.HK）的战略合作签约仪式，到如今正式执掌一家百亿市值的上市创新药企，近期周云曙接任先声药业CEO引发市场关注。3月25日，先声药业在公布2025年财报的同时官宣了一项人事任命，宣布周云曙获委任为公司首席执行官。在业绩发布会上，周云曙表示，先声药业2026年的经营目标是营业收入突破100亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603273687234875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622814803","title":"港股异动 | 先声药业(02096)午前涨近8% 恒瑞医药前董事长周云曙正式出任先声药业CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2622814803","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622814803?lang=zh_cn&edition=full","pubTime":"2026-03-27 12:01","pubTimestamp":1774584119,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，先声药业午前涨近8%，截至发稿，涨7.87%，报12.06港元，成交额4559.2万港元。消息面上，3月25日，先声药业公告披露，恒瑞医药原董事长周云曙正式加盟，获聘首席执行官。先声药业近日发布的年度业绩显示。目前，先声药业已拥有10款上市创新药，还有超5款临近上市创新药，预计于2026-2028年获批，蓄力未来持续增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1420260.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","LU0359201885.HKD","LU2543165471.USD","LU2097828631.EUR","LU2097828474.EUR","BK1583","LU1023057109.AUD","LU2289578879.USD","LU2097828557.USD","LU1064131003.USD","LU1969619763.USD","LU0405327148.USD","LU2580892789.USD","BK0188","BK0028","LU0405327494.USD","600276","LU1997245094.SGD","LU2148510915.USD","BK0012","BK0183","LU2097828805.USD","BK0060","LU2580892862.HKD","01276","LU1781817850.SGD","LU1146622755.USD","LU2495084118.USD","LU1997245177.USD","BK4588","VXUS","LU1655091616.SGD","BK4585","LU0359202008.SGD","LU2488822045.USD","LU1255011170.USD","LU1580142542.USD","LU1328615791.USD","LU1997244956.HKD","BK0196","LU2097828714.EUR","LU0359201612.USD","LU1064130708.USD","02096","BK1191","LU2328871848.SGD","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111219149","title":"异动解读 | 业绩超预期叠加新CEO公布百亿目标，先声药业盘中大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=1111219149","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111219149?lang=zh_cn&edition=full","pubTime":"2026-03-27 10:02","pubTimestamp":1774576968,"startTime":"0","endTime":"0","summary":"先声药业今日盘中股价大幅上涨5.46%，市场表现活跃。消息面上，公司于前一晚发布了2025年度业绩报告，显示其总收入达77.31亿元，同比增长16.5%；归母净利润为13.44亿元，同比大幅增长86.2%。与此同时，公司宣布了重要人事变动，由拥有近三十年行业经验的资深人士周云曙接任首席执行官。在随后的业绩会上，新任CEO周云曙公布了公司2026年的“双30”目标：营业收入挑战100亿元，经调整净利润同比增长30%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622289783","title":"信达生物2025年首次扭亏为盈；周云曙出任先声药业CEO | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2622289783","media":"每日经济新闻","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622289783?lang=zh_cn&edition=full","pubTime":"2026-03-27 07:00","pubTimestamp":1774566006,"startTime":"0","endTime":"0","summary":"丨2026年3月27日星期五丨NO.1京东健康宿迁天宁股权结构调整3月26日，京东健康宣布，为提高行政效率，李娅云于2026年3月26日订立股权转让协议，据此李娅云同意将其在宿迁天宁持有的30%股权转让予隋婷婷。由于一名登记股东变更，宿迁天宁、外商独资企业及新登记股东订立新合同安排，现有合同安排同时终止。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603273686096042.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603273686096042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1574","LU1997245177.USD","LU1655091616.SGD","LU0405327494.USD","09939","LU2097828631.EUR","LU0455707207.USD","LU2242644610.SGD","LU2580892789.USD","159938","BK0028","LU0405327148.USD","01801","BK0060","BK0239","BK1589","LU1064130708.USD","BK0012","02096","LU2580892862.HKD","HK0000165453.HKD","LU2289578879.USD","BK0196","BK1191","LU1255011170.USD","LU1781817850.SGD","LU1328615791.USD","LU1997245094.SGD","LU2148510915.USD","LU2097828805.USD","BK0188","BK1583","LU1146622755.USD","LU2097828714.EUR","BK0183","LU1820825898.SGD","LU1969619763.USD","LU2495084118.USD","LU1064131003.USD","LU2097828557.USD","BK1161","LU2097828474.EUR","LU0502904849.HKD","LU2488822045.USD","LU1580142542.USD","LU2328871848.SGD","600276","LU1997244956.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622731850","title":"先声药业(02096.HK)：授出合共216.9万份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2622731850","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622731850?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:47","pubTimestamp":1774529225,"startTime":"0","endTime":"0","summary":"格隆汇3月26日丨先声药业(02096.HK)布，于2026年3月26日，其议决根据2021年受限制股份单位计划按零代价向合共54名合资格参与者授出合共216.9万份受限制股份单位(相当于216.9万股相关股份)，惟须待承授人接纳。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260326/32102134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172271995","title":"先声药业：3月26日回购197.40万股，耗资约2,203.24万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1172271995","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172271995?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:06","pubTimestamp":1774526800,"startTime":"0","endTime":"0","summary":"先声药业集团有限公司于2026年3月26日公告，披露该公司在香港联交所场内回购股份。根据公告，公司本次回购股份数量为1,974,000股，占已发行股本约0.076%。每股回购价介乎港币10.9444元至11.3272元，合计耗资约22,032,406港元。公司此前于2025年6月13日获得购回授权，授权可购回的总数为247,469,761股；截至目前，已根据购回授权回购12,825,000股，占授权决议通过当日公司已发行股本约0.5182%。公告同时指出，公司确认已遵守香港联交所证券上市规则及其他相关法律规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622852066","title":"先声药业(02096)3月26日斥资2203.24万港元回购197.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2622852066","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622852066?lang=zh_cn&edition=full","pubTime":"2026-03-26 20:03","pubTimestamp":1774526585,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先声药业(02096)发布公告，于2026年3月26日斥资2203.24万港元回购197.4万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622070832","title":"先声药业(02096)附属拟3076.32万元收购上海先声诊断技术全部股权 旨在打造开放式创新交流中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2622070832","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622070832?lang=zh_cn&edition=full","pubTime":"2026-03-25 23:10","pubTimestamp":1774451422,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先声药业 发布公告，于2026年3月25日，买方先声药业有限公司与卖方江苏先声诊断技术有限公司订立股权转让协议，买方同意收购而卖方同意出售目标公司上海先声诊断技术有限公司的全部股权，现金代价为人民币3076.32万元。收购事项完成后，目标公司将成为公司的间接全资附属公司，且目标公司的财务业绩将并入集团的财务报表。收购事项旨在打造一个开放式的创新交流中心，该中心是落实创新驱动发展战略的一项重要战略设施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1191","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622077224","title":"先声药业(02096)：麦宝文获委任为联席公司秘书","url":"https://stock-news.laohu8.com/highlight/detail?id=2622077224","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622077224?lang=zh_cn&edition=full","pubTime":"2026-03-25 23:06","pubTimestamp":1774451193,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先声药业(02096)发布公告，黄慧玲女士已辞任公司的联席公司秘书，自2026年3月25日生效。麦宝文女士已获委任为联席公司秘书，自2026年3月25日起生效。万玉山先生将继续出任另一名联席公司秘书。联交所已确认万先生符合联交所上市规则第3.28条所规定，并已具备担任公司的公司秘书资格。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02096","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622077226","title":"先声药业(02096)2025年营收达77.31亿元再创新高 创新药收入占比持续提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2622077226","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622077226?lang=zh_cn&edition=full","pubTime":"2026-03-25 23:06","pubTimestamp":1774451165,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先声药业 公布2025年业绩，收入人民币77.31亿元，同比增长16.5%;创新药业务收入人民币63.04亿元，占总收入比率81.5%，较2024年增长27.9%。归属于公司权益股东的利润人民币13.44亿元，同比增长86.2%;经调整归属于公司权益股东的利润人民币12.80亿元，同比增长27.1%。公告称，收入增长主要归因于创新药收入及授权许可收入的增加。创新药业务加速增长，商业化创新药已拓展至十款，营收再创新高，创新药收入占比持续提升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419114.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","02096","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622772640","title":"先声药业(02096)：周云曙获委任为首席执行官","url":"https://stock-news.laohu8.com/highlight/detail?id=2622772640","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622772640?lang=zh_cn&edition=full","pubTime":"2026-03-25 23:02","pubTimestamp":1774450923,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先声药业(02096)发布公告，周云曙博士已获委任为首席执行官，自2026年3月25日起生效。在此职务中，彼作为高级管理人员，负责监督本集团业务营运的整体管理。周博士向董事会汇报，并须接受董事会的指导及监督。为专注集团长期战略制定、重大投资决策及监督董事会履职，任晋生先生将自2026年3月25日起不再担任首席执行官。任先生将继续担任公司董事长兼执行董事。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1419110.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1064131003.USD","LU2580892789.USD","LU0405327494.USD","BK0183","LU1255011170.USD","BK0188","LU1820825898.SGD","BK1191","LU1781817850.SGD","LU1580142542.USD","BK0196","LU2097828474.EUR","LU2097828714.EUR","LU1997245177.USD","02096","BK1583","LU1997245094.SGD","LU1997244956.HKD","LU1328615791.USD","LU2289578879.USD","LU2580892862.HKD","BK0012","LU1064130708.USD","BK0239","LU2495084118.USD","LU2097828631.EUR","LU1146622755.USD","LU2328871848.SGD","LU2097828805.USD","LU1969619763.USD","LU0405327148.USD","LU2488822045.USD","600276","LU2097828557.USD","LU2148510915.USD","BK0028","LU1655091616.SGD","BK0060"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199161470","title":"先声药业将于2026年7月13日派发末期股息每股0.18元","url":"https://stock-news.laohu8.com/highlight/detail?id=1199161470","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1199161470?lang=zh_cn&edition=full","pubTime":"2026-03-25 22:51","pubTimestamp":1774450306,"startTime":"0","endTime":"0","summary":"先声药业(02096)3月25日发布公告，宣派截至2025年12月31日止年度之末期股息每股人民币0.18元，尚待股东于2026年6月12日举行的股东大会上批准。公告显示，该股将于2026年6月17日除净，并于2026年6月24日记录在册。公司计划于2026年7月13日派发股息。\n根据公告，香港过户登记处将于2026年6月19日至6月24日暂停办理股份过户登记手续，截止递交过户文件的时间为2026年6月18日16时30分。公司预设派发货币为港元，实际人民币兑港元汇率有待公布。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ba25b1588c8e6692f0294260f00552f3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620425231","title":"先声药业(02096)：SIM0237于2026年欧洲泌尿外科学会年会公布非肌层浸润性膀胱癌的I/II期临床研究数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2620425231","media":"智通财经","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620425231?lang=zh_cn&edition=full","pubTime":"2026-03-17 18:45","pubTimestamp":1773744323,"startTime":"0","endTime":"0","summary":"智通财经APP讯，先声药业 发布公告，本集团自主研发的创新融合蛋白 SIM0237于2026年欧洲泌尿外科学会年会公布用于治疗卡介苗无应答高危非肌层浸润性膀胱癌的I/II 期临床研究数据。截至数据截止日，共有49名患者接受SIM0237单药膀胱灌注治疗。整体结果显示SIM0237在BCG无应答高危NMIBC患者中展现出具有前景的临床疗效信号。安全性方面，SIM0237膀胱灌注给药显示出良好的安全性及耐受性，且血清样本分析未检测到药物的系统性暴露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"先声药业(02096)：SIM0237于2026年欧洲泌尿外科学会年会公布非肌层浸润性膀胱癌的I/II期临床研究数据","news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","02096","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619416008","title":"先声药业(02096.HK)3月25日举行董事会会议考虑及批准全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=2619416008","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619416008?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:17","pubTimestamp":1773393423,"startTime":"0","endTime":"0","summary":"格隆汇3月13日丨先声药业(02096.HK)公布，董事会会议将于2026年3月25日(星期三)举行，藉以(其中包括)考虑及批准公司及其附属公司截至2025年12月31日止年度的全年业绩及其发布，并建议派发末期股息(如有)等事项。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260313/32066692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1191","BK1583","02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618138702","title":"每日卖空追踪 | 先声药业 03月12日卖空量成交8.2万股，卖空比例为2.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618138702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618138702?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304228,"startTime":"0","endTime":"0","summary":"先声药业北京时间03月12日，跌1.77%，卖空量成交8.2万股，较上一交易日减少53.93%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163341a6ba50ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163341a6ba50ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","BK1583","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618189598","title":"每日卖空追踪 | 先声药业 03月11日卖空量成交6.9万股，卖空比例为3.95%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618189598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618189598?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:30","pubTimestamp":1773217827,"startTime":"0","endTime":"0","summary":"先声药业北京时间03月11日，跌0.75%，卖空量成交6.9万股，较上一交易日减少84.14%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163327a460b629&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311163327a460b629&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02096","BK1191","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175955561","title":"先声药业（02096）更新2月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1175955561","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175955561?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:52","pubTimestamp":1772614349,"startTime":"0","endTime":"0","summary":"先声药业集团有限公司于2026年3月4日披露2026年2月股份变动月报表。截至2026年2月28日，公司已发行股份总数为2,595,697,618股，与上月底保持一致，未有新增发行、回购注销或库藏股变动。报告期内普通股的已发行股份数量连续保持2,595,697,618股，库存股份数量维持0股，公司确认符合最低15.45%的上市时公众持股量要求。公司声明按照香港联交所《上市规则》及相关法律规范维持充足公众持股量。截至2月末，股本总数稳定，公司股本结构无实质性变化。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617972325","title":"每日卖空追踪 | 先声药业 03月04日卖空量成交17.9万股，卖空比例为3.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617972325","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617972325?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:30","pubTimestamp":1772613027,"startTime":"0","endTime":"0","summary":"先声药业北京时间03月04日，跌1.99%，卖空量成交17.9万股，较上一交易日减少65.04%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163341a6a14e69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304163341a6a14e69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","02096"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.simcere.com","stockEarnings":[{"period":"1week","weight":0.1933},{"period":"1month","weight":0.1429},{"period":"3month","weight":0.1295},{"period":"6month","weight":0.0258},{"period":"1year","weight":0.6658},{"period":"ytd","weight":0.1295}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":-0.0294},{"period":"3month","weight":-0.0131},{"period":"6month","weight":-0.068},{"period":"1year","weight":0.0899},{"period":"ytd","weight":-0.0131}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"先声药业集团有限公司是一家从事药品的研发、生产和销售的公司。该公司的主要产品为仿制药，包括用于中枢神经系统疾病的产品必存、用于肿瘤疾病的产品捷百舒和捷佰立、以及用于自身免疫疾病的产品英太青。该公司还从事生产创新药，比如用于肿瘤疾病的恩度。该公司还从事为医疗机构销售的第三方药品提供推广服务。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.093182},{"month":2,"riseRate":0.666667,"avgChangeRate":0.070781},{"month":3,"riseRate":0.5,"avgChangeRate":-0.014071},{"month":4,"riseRate":0.666667,"avgChangeRate":0.018358},{"month":5,"riseRate":0.8,"avgChangeRate":0.158743},{"month":6,"riseRate":0.6,"avgChangeRate":0.036684},{"month":7,"riseRate":0.2,"avgChangeRate":-0.0521},{"month":8,"riseRate":0.4,"avgChangeRate":-0.05132},{"month":9,"riseRate":0.4,"avgChangeRate":-0.0324},{"month":10,"riseRate":0.8,"avgChangeRate":0.108781},{"month":11,"riseRate":0.666667,"avgChangeRate":0.044275},{"month":12,"riseRate":0.5,"avgChangeRate":0.000552}],"exchange":"SEHK","name":"先声药业","nameEN":"SIMCERE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供先声药业(02096)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"先声药业,02096,先声药业股票,先声药业股票老虎,先声药业股票老虎国际,先声药业行情,先声药业股票行情,先声药业股价,先声药业股市,先声药业股票价格,先声药业股票交易,先声药业股票购买,先声药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"先声药业(02096)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供先声药业(02096)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}